WORK Medical Technology Group LTD Ordinary Shares (WOK)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $5.36M
Last updated: Nov 17, 2026 at 11:05 AM ET
WORK Medical Technology Group LTD Ordinary Shares (WOK) Financials: Revenue, Profit and Cash Flow
WORK Medical Technology Group LTD Ordinary Shares reported revenue of $9.85M for the fiscal year ended Sep 30, 2025, down 14.4% from the year before. That year, net income was -$1.07M with a net margin of -10.9%, operating cash flow was $6.24M and free cash flow was $4.91M. The quarter ended Jun 30, 2026 had revenue of $5.41M and net income of -$3.41M.
Revenue and Margins
The operating margin was -25.3% in the fiscal year ended Sep 2025. Over the 5 years to Sep 2025, revenue fell from $52.53M, a compound annual decline of 28.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $9.85M | -14.4% | 23.8% | -25.3% | -10.9% |
| Sep 2024 | $11.51M | -15.2% | 24.9% | -32.1% | -30.4% |
| Sep 2023 | $13.57M | -31.2% | 30.5% | 3.6% | 0.8% |
| Sep 2022 | $19.71M | -57.0% | 22.4% | 9.3% | 4.4% |
| Sep 2021 | $45.86M | -12.7% | 18.8% | 16.7% | 13.0% |
| Sep 2020 | $52.53M | N/A | 20.7% | 11.4% | 2.2% |
Income Statement
In the fiscal year ended Sep 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|---|---|
| Revenue | $9.85M | $11.51M | $13.57M | $19.71M | $45.86M | $52.53M |
| Cost of revenue | $7.50M | $8.64M | $9.42M | $15.29M | $37.22M | $41.68M |
| Gross profit | $2.34M | $2.87M | $4.14M | $4.42M | $8.64M | $10.85M |
| Research and development | $435.31K | $302.51K | $301.64K | $183.90K | $186.45K | $797.38K |
| Operating income | -$2.50M | -$3.70M | $486.46K | $1.82M | $7.67M | $5.99M |
| Net income | -$1.07M | -$3.49M | $112.03K | $865.21K | $5.96M | $1.16M |
| EBITDA | $339.37K | -$1.71M | $2.08M | $4.72M | $11.87M | N/A |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.41M | $5.31M | $2.27M | $4.54M | $2.27M | $6.20M | $3.10M | $5.31M | $2.65M | $4.55M | $2.28M | $9.01M |
| Gross profit | $530.35K | $782.56K | $781.15K | $1.56M | $781.15K | $1.33M | $662.70K | $1.54M | $771.49K | $242.92K | $121.46K | $3.90M |
| Operating income | -$3.54M | -$929.69K | -$783.18K | -$1.57M | -$783.18K | -$3.54M | -$1.77M | -$507.69K | -$253.85K | -$1.52M | -$760.05K | $2.01M |
| Net income | -$3.41M | -$1.09M | $6.58K | $13.16K | $6.58K | -$3.72M | -$1.86M | $226.53K | $113.26K | -$1.36M | -$681.85K | $1.48M |
Balance Sheet
As of Sep 2025, short-term debt of $6.41M exceeded cash and equivalents by $2.32M.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|---|---|
| Total assets | $33.16M | $36.25M | $29.96M | $25.54M | $30.66M | $56.20M |
| Current assets | $20.46M | $20.83M | $22.15M | $16.61M | $18.15M | $40.37M |
| Cash and equivalents | $4.09M | $6.56M | $1.60M | $731.18K | $508.71K | $200.40K |
| Total liabilities | $11.99M | $20.18M | $18.97M | $14.35M | $19.26M | $50.27M |
| Short-term debt | $6.41M | $13.47M | $9.05M | $6.23M | $6.60M | $3.46M |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | $589.14K |
| Shareholder equity | $18.35M | $13.19M | $9.88M | $10.00M | $10.04M | $4.90M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $48.32M | $48.31M | $33.16M | $33.16M | $34.71M | $34.71M | $34.71M | $36.25M | $36.25M | $32.49M | $32.49M | $29.96M |
| Total liabilities | $15.83M | $15.83M | $11.99M | $11.99M | $19.00M | $19.00M | $19.00M | $20.18M | $20.18M | $21.16M | $21.16M | $18.97M |
| Cash and equivalents | $3.25M | $3.25M | $4.09M | $4.09M | $2.00M | $2.00M | $2.00M | $6.56M | $6.56M | $1.04M | $1.04M | $1.60M |
| Shareholder equity | $30.13M | $30.12M | $18.35M | $18.34M | $12.95M | $12.95M | $12.95M | $13.19M | $13.19M | $10.21M | $10.21M | $9.88M |
Cash Flow
In the fiscal year ended Sep 2025, free cash flow was 78.7% of operating cash flow.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $6.24M | -$2.23M | $2.21M | -$2.26M | -$7.18M | $27.20M |
| Capital expenditures | $1.33M | $9.26M | $583.30K | $2.01M | $60.00K | $17.55M |
| Free cash flow | $4.91M | -$11.49M | $1.63M | -$4.27M | -$7.24M | $9.65M |
| Investing cash flow | -$7.61M | -$9.06M | -$583.30K | -$1.35M | -$60.00K | -$16.84M |
| Financing cash flow | -$898.21K | $15.66M | -$728.72K | $3.57M | $7.99M | -$10.28M |
Quarterly
| Line item | Jun 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.91M | $9.04M | -$2.80M | -$5.59M | -$1.40M | -$963.40K | -$481.70K | -$1.26M | -$632.34K | $1.49M | $745.14K | $719.46K |
| Capital expenditures | $3.66M | $1.09M | $119.34K | $238.68K | $119.34K | $9.20M | $4.60M | $28.78K | $14.39K | $83.24K | $41.62K | $666.54K |
| Free cash flow | -$13.57M | $7.95M | -$2.92M | -$5.83M | -$1.52M | -$10.16M | -$5.08M | -$1.29M | -$646.73K | $1.41M | $703.52K | $52.92K |
Frequently Asked Questions About WOK
What is WORK Medical Technology Group LTD Ordinary Shares' annual revenue?
WORK Medical Technology Group LTD Ordinary Shares reported revenue of $9.85M for the fiscal year ended Sep 30, 2025.
How fast is WORK Medical Technology Group LTD Ordinary Shares' revenue growing?
Revenue was down 14.4% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -20.6%.
Is WORK Medical Technology Group LTD Ordinary Shares profitable?
No. WORK Medical Technology Group LTD Ordinary Shares reported net income of -$1.07M for the fiscal year ended Sep 30, 2025, with a net margin of -10.9%.
How much free cash flow does WOK generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $6.24M minus capital expenditures of $1.33M produced free cash flow of $4.91M.
How much debt does WORK Medical Technology Group LTD Ordinary Shares have?
The balance sheet dated Sep 30, 2025 reported short-term debt of $6.41M and cash and equivalents of $4.09M.
WOK pages: Overview, Financials